Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome

Main Article Content

Dan Li Jing Zhang Xiaofen Zhang Yifan Chang Sten H. Vermund

Abstract

Purpose of Review. Our review aims to compare and contrast Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and SARS-CoV-2/COVID-19's impact on maternal and neonatal outcomes. We have made significant progress in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome prevention and treatment over the last few decades. Drawing on empirical evidence with past public health crises can offer valuable insights into dealing with current and future pandemics. Therefore, it is imperative to conduct a comparative analysis of the resemblances and disparities existing between Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and SARS-CoV-2/COVID-19.This research endeavor represents a pioneering and all-encompassing examination, aiming to discern and comprehend the parallels and contrasts in the respective impacts of SARS-CoV-2 and Human Immunodeficiency Virus on pregnancy.


Recent Findings. Based on the current evidence, there is no indication that pregnancy increases women's susceptibility to acquiring Human Immunodeficiency Virus or SARS-CoV-2. Nevertheless, the state of being pregnant was correlated with the worsening of diseases and their progression. Both Human Immunodeficiency Virus and SARS-CoV-2 pose increased risks of maternal mortality and several obstetric complications, including premature birth and pre-eclampsia. While the vertical transmission of Human Immunodeficiency Virus is well-established, a comprehensive understanding of the vertical transmission of SARS-CoV-2 remains elusive, emphasizing the need for further investigations. Initial data suggest low SARS-CoV-2 vertical transmission rates in the setting of proper preventative interventions and universal screening. A cesarean delivery could reduce the risk of mother-to-child transmission in Human Immunodeficiency Virus-infected women with high viral loads or poor adherence to antiretroviral therapy (ART). However, it did not offer additional protection for Human Immunodeficiency Virus-infected women who adhered to Adherence to Antiretroviral Therapy or those with COVID-19. Human Immunodeficiency Virus and SARS-CoV-2 were linked to neonatal complications such as stillbirth, low birth weight, and neonatal intensive care unit (ICU) admissions. The universal testing of both pregnant patients and neonates is an effective strategy to prevent the spread and complications of both Human Immunodeficiency Virus and SARS-CoV-2. Human Immunodeficiency Virus control largely relies on preventing vertical transmission and medications during pregnancy and postpartum, whereas safety behaviors and vaccines have proven effective in preventing SARS-CoV-2 vertical transmissions.


Summary. This review aims to compare and contrast the impact of Human Immunodeficiency Virus and SARS-CoV-2 on pregnancy outcomes, vertical transmissions, delivery modalities, neonatal outcomes, and clinical management. SARS-CoV-2 and Human Immunodeficiency Virus were associated with significant obstetric-related complications, making close clinical monitoring and preparation essential. Integration of SARS-CoV-2/COVID-19 management with reproductive health services is crucial to ensuring maternal and neonatal outcomes. Our review is not only the first to establish a groundwork for the current state of knowledge and its clinical implications on this topic, but it also sheds new insights for future research directions.


Comparing Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and SARS-CoV-2 in terms of their impact on maternal and neonatal outcomes provides valuable insights despite their differences. Leveraging Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome research can help understand SARS-CoV-2 effects on pregnancy. Both infections pose risks to pregnant individuals and their fetuses, leading to increased maternal mortality and complications. Identifying common patterns and risk factors can improve clinical management for pregnant individuals with SARS-CoV-2. While a direct observational study for this comparison may not be feasible, comparing with Human Immunodeficiency Virus offers an ethical and practical approach. However, specific studies on SARS-CoV-2 are still necessary to gather detailed data on maternal and fetal outcomes.

Keywords: COVID-19, SARS-CoV-2, HIV/AIDS, Pregnancy, Maternal Outcomes, Newborn Outcomes, Vertical Transmissions, Breastfeeding, Vaccine, Pandemic, Infectious Disease

Article Details

How to Cite
LI, Dan et al. Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Research Archives, [S.l.], v. 12, n. 4, apr. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5205>. Date accessed: 27 may 2024. doi: https://doi.org/10.18103/mra.v12i4.5205.
Section
Research Articles

References

1. Illanes-Álvarez F, Márquez-Ruiz D, Márquez-Coello M, Cuesta-Sancho S, Girón-González JA. Similarities and differences between HIV and SARS-CoV-2. Int J Med Sci. 2021;18(3):846-851. Doi:10.7150/ijms.50133
2. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection--United States, 1985-2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592-597.
3. COVID-19 2023 Update – Ending of the Public Health Emergency. Accessed July 27, 2023. https://portal.ct.gov/DPH/Communications/Health-Topics/COVID-19-2023-Update---Ending-of-the-Public-Health-Emergency
4. Vermund SH, Leigh-Brown AJ. The HIV Epidemic: High-Income Countries. Cold Spring Harb Perspect Med. 2012;2(5):a007195. Doi:10.1101/cshperspect.a007195
5. HIV-prevention science at a crossroads: advances in reducing sexual risk - PMC. Accessed July 27, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995247/
6. Allinder SM, Summers T, Downie R, Fleischman J, Dattilo L, Peck K. Recommendations from the CSIS HIV Working Group.
7. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet Lond Engl. 2020;395(10223):470-473. Doi:10.1016/S0140-6736(20)30185-9
8. Fennelly KP. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med. 2020;8(9):914-924. Doi:10.1016/S2213-2600(20)30323-4
9. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis | CMAJ. Accessed July 27, 2023. https://www.cmaj.ca/content/193/16/E540
10. Graybill LA, Kasaro M, Freeborn K, et al. Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis. AIDS Lond Engl. 2020;34(5):761-776. Doi:10.1097/QAD.0000000000002487
11. Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners | The Journal of Infectious Diseases | Oxford Academic. Accessed July 27, 2023. https://academic.oup.com/jid/article/218/1/16/4915924
12. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020 - PubMed. Accessed July 27, 2023. https://pubmed.ncbi.nlm.nih.gov/33151921/
13. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. Doi:10.1136/bmj.m3320
14. Badr DA, Mattern J, Carlin A, et al. Are clinical outcomes worse for pregnant women at ≥20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol. 2020;223(5):764-768. Doi:10.1016/j.ajog.2020.07.045
15. Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571-580. Doi:10.1097/AOG.0000000000004339
16. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis - PMC. Accessed July 27, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051832/
17. DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol. 2021;224(5):510.e1-510.e12. Doi:10.1016/j.ajog.2020.11.022
18. Joseph N, Stanhope K, Badell M, Horton J, Boulet S, Jamieson D. Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA. Emerg Infect Dis. 2020;26:2786-2788. Doi:10.3201/eid2611.203091
19. Yanes-Lane M, Winters N, Fregonese F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PloS One. 2020;15(11):e0241536. Doi:10.1371/journal.pone.0241536
20. Jering KS, Claggett BL, Cunningham JW, et al. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021;181(5):714-717. Doi:10.1001/jamainternmed.2020.9241
21. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis - ScienceDirect. Accessed July 27, 2023. https://www.sciencedirect.com/science/article/pii/S0002937822006809
22. Karimi L, Makvandi S, Vahedian-Azimi A, Sathyapalan T, Sahebkar A. Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis. J Pregnancy. 2021;2021:8870129. Doi:10.1155/2021/8870129
23. Galang RR, Newton SM, Woodworth KR, et al. Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020-5 March 2021. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(Suppl 1):S17-S23. Doi:10.1093/cid/ciab432
24. Calvert C, Ronsmans C. Pregnancy and HIV disease progression: a systematic review and meta-analysis. Trop Med Int Health. 2015;20(2):122-145. Doi:10.1111/tmi.12412
25. Boettcher LB, Metz TD. Maternal and neonatal outcomes following SARS-CoV-2 infection. Semin Fetal Neonatal Med. 2023;28(1):101428. Doi:10.1016/j.siny.2023.101428
26. Villar J, Ariff S, Gunier RB, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817-826. Doi:10.1001/jamapediatrics.2021.1050
27. Arab K, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet. 2017;295(3):599-606. Doi:10.1007/s00404-016-4271-y
28. Calvert C, Ronsmans C. HIV and the Risk of Direct Obstetric Complications: A Systematic Review and Meta-Analysis. PLOS ONE. 2013;8(10):e74848. Doi:10.1371/journal.pone.0074848
29. Huntley BJF, Mulder IA, Di Mascio D, et al. Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review and Meta-analysis. Obstet Gynecol. 2021;137(4):585-596. Doi:10.1097/AOG.0000000000004320
30. Khalil A, von Dadelszen P, Draycott T, Ugwumadu A, O’Brien P, Magee L. Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA. 2020;324(7):705-706. Doi:10.1001/jama.2020.12746
31. Elsaddig M, Khalil A. Effects of the COVID pandemic on pregnancy outcomes. Best Pract Res Clin Obstet Gynaecol. 2021;73:125-136. Doi:10.1016/j.bpobgyn.2021.03.004
32. Norman M, Navér L, Söderling J, et al. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. JAMA. 2021;325(20):2076-2086. Doi:10.1001/jama.2021.5775
33. Ko JY, DeSisto CL, Simeone RM, et al. Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(Suppl 1):S24-S31. Doi:10.1093/cid/ciab344
34. Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021;225(5):522.e1-522.e11. Doi:10.1016/j.ajog.2021.05.016
35. Hutagaol IO, Arini, Mujianti C, Setyawati E, Situmorang BHL. Neonatal Outcomes Profile in Pregnant Women with Covid-19 Infection. HIV Nurs. 2023;23(3):274-277.
36. Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2020;56(1):15-27. Doi:10.1002/uog.22088
37. Shlomai NO, Kasirer Y, Strauss T, et al. Neonatal SARS-CoV-2 Infections in Breastfeeding Mothers. Pediatrics. 2021;147(5):e2020010918. Doi:10.1542/peds.2020-010918
38. Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2020;150(1):47-52. Doi:10.1002/ijgo.13182
39. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1-111.e14. Doi:10.1016/j.ajog.2020.04.014
40. Cosma S, Carosso AR, Cusato J, et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol. 2021;224(4):391.e1-391.e7. Doi:10.1016/j.ajog.2020.10.005
41. la Cour Freiesleben N, Egerup P, Hviid KVR, et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod Oxf Engl. 2021;36(1):40-47. Doi:10.1093/humrep/deaa311
42. Rotshenker-Olshinka K, Volodarsky-Perel A, Steiner N, Rubenfeld E, Dahan MH. COVID-19 pandemic effect on early pregnancy: are miscarriage rates altered, in asymptomatic women? Arch Gynecol Obstet. 2021;303(3):839-845. Doi:10.1007/s00404-020-05848-0
43. Cheshire M, Kingston M, McQuillan O, Gittins M. Are HIV-related factors associated with pre-term delivery in a UK inner city setting? J Int AIDS Soc. 2012;15:18223. Doi:10.7448/IAS.15.6.18223
44. Goldshtein I, Nevo D, Steinberg DM, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. 2021;326(8):728-735. Doi:10.1001/jama.2021.11035
45. Jackson-Gibson M, Diseko M, Caniglia EC, et al. Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status. Obstet Gynecol. 2023;141(1):135-143. Doi:10.1097/AOG.0000000000005020
46. The Impact of COVID-19 on Adverse Birth Outcomes in Botswana by HIV Status. Accessed July 27, 2023. https://www.natap.org/2022/CROI/croi_101.htm
47. Jia Y, Lu F, Sun X, Vermund SH. SOURCES OF DATA FOR IMPROVED SURVEILLANCE OF HIV/AIDS IN CHINA. Southeast Asian J Trop Med Public Health. 2007;38(6):1041-1052.
48. Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique - PMC. Accessed July 27, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891693/
49. Alfvén T, Erkkola T, Ghys PD, et al. Global AIDS Reporting-2001 to 2015: Lessons for Monitoring the Sustainable Development Goals. AIDS Behav. 2017;21(Suppl 1):5-14. Doi:10.1007/s10461-016-1662-9
50. Berhan Y. Predictors of perinatal mortality associated with placenta previa and placental abruption: an experience from a low income country. J Pregnancy. 2014;2014:307043. Doi:10.1155/2014/307043
51. Kalumba VMS, Moodley J, Naidoo TD. Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case-control study. Cardiovasc J Afr. 2013;24(2):24-27. Doi:10.5830/CVJA-2012-078
52. Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG Int J Obstet Gynaecol. 2020;127(11):1374-1380. Doi:10.1111/1471-0528.16339
53. Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2011;8(1):62-72. Doi:10.1007/s11904-010-0063-3
54. FABMGG FRL PhD, RN, FAAN JDD PhD, RN. The Person with HIV/AIDS: Nursing Perspectives. Springer Publishing Company; 2009.
55. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41(11):1654-1661. Doi:10.1086/498029
56. Ehrnst A, Lindgren S, Dictor M, et al. HIV in pregnant women and their offspring: evidence for late transmission. Lancet Lond Engl. 1991;338(8761):203-207. Doi:10.1016/0140-6736(91)90347-r
57. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285(6):709-712. Doi:10.1001/jama.285.6.709
58. Lehman DA, Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol. 2007;17(6):381-403. Doi:10.1002/rmv.543
59. Shen R, Smythies LE, Clements RH, Novak L, Smith PD. Dendritic cells transmit HIV-1 through human small intestinal mucosa. J Leukoc Biol. 2010;87(4):663-670. Doi:10.1189/jlb.0909605
60. Veazey R, Lackner A. The mucosal immune system and HIV-1 infection. AIDS Rev. 2003;5(4):245-252.
61. Lapenta C, Boirivant M, Marini M, et al. Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol. 1999;29(4):1202-1208. Doi:10.1002/(SICI)1521-4141(199904)29:04<1202::AID-IMMU1202>3.0.CO;2-O
62. Kourtis AP, Ibegbu CC, Wiener J, et al. Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study. J Infect Dis. 2013;208(4):653-661. Doi:10.1093/infdis/jit221
63. Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res J Lab Clin Med. 2023;251:84-95. Doi:10.1016/j.trsl.2022.08.007
64. Goh XL, Low YF, Ng CH, Amin Z, Ng YPM. Incidence of SARS-CoV-2 vertical transmission: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2021;106(1):112-113. Doi:10.1136/archdischild-2020-319791
65. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis - PMC. Accessed July 27, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392880/
66. Begnel ER, Chohan BH, Ojee E, et al. HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants. PloS One. 2023;18(1):e0278675. Doi:10.1371/journal.pone.0278675
67. Schwartz DA. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020;144(7):799-805. Doi:10.5858/arpa.2020-0901-SA
68. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323(18):1843-1844. Doi:10.1001/jama.2020.3786
69. Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-389. Doi:10.1080/22221751.2020.1729071
70. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020;4(10):721-727. Doi:10.1016/S2352-4642(20)30235-2
71. Pace RM, Williams JE, Järvinen KM, et al. COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity. MedRxiv Prepr Serv Health Sci. Published online September 18, 2020:2020.09.16.20196071. Doi:10.1101/2020.09.16.20196071
72. Prevention C for DC and, America HMA of the IDS of, DiseasesSociety PI, Council (OARAC) HP on T of HDP and P of PTAWG of the O of ARA. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. In: ClinicalInfo.HIV.Gov [Internet]. US Department of Health and Human Services; 2023. Accessed July 27, 2023. https://www.ncbi.nlm.nih.gov/books/NBK586310/
73. Figueroa-Romero A, Mendes A, Mombo-Ngoma G, et al. Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations: protocol of a multicentre prospective cohort study (MA-CoV project). BMJ Open. 2023;13(5):e067083. Doi:10.1136/bmjopen-2022-067083
74. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med. 1996;334(25):1617-1623. Doi:10.1056/NEJM199606203342501
75. Walker KF, O’Donoghue K, Grace N, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG Int J Obstet Gynaecol. 2020;127(11):1324-1336. Doi:10.1111/1471-0528.16362
76. Cai J, Tang M, Gao Y, et al. Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review. Front Med. 2021;8:634949. Doi:10.3389/fmed.2021.634949
77. Martínez-Perez O, Vouga M, Cruz Melguizo S, et al. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain. JAMA. 2020;324(3):296-299. Doi:10.1001/jama.2020.10125
78. Liu C, Sun W, Wang C, Liu F, Zhou M. Delivery during extracorporeal membrane oxygenation (ECMO) support of pregnant woman with severe respiratory distress syndrome caused by influenza: a case report and review of the literature. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2019;32(15):2570-2574. Doi:10.1080/14767058.2018.1439471
79. Slayton-Milam S, Sheffels S, Chan D, Alkinj B. Induction of Labor in an Intubated Patient With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2020;136(5):962-964. Doi:10.1097/AOG.0000000000004044
80. Reale SC, Fields KG, Lumbreras-Marquez MI, et al. Association Between Number of In-Person Health Care Visits and SARS-CoV-2 Infection in Obstetrical Patients. JAMA. 2020;324(12): 1210-1212. Doi:10.1001/jama.2020.15242
81. Kc A, Gurung R, Kinney MV, et al. Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study. Lancet Glob Health. 2020;8(10):e1273-e1281. Doi:10.1016/S2214-109X(20)30345-4
82. Kumari V, Mehta K, Choudhary R. COVID-19 outbreak and decreased hospitalisation of pregnant women in labour. Lancet Glob Health. 2020;8(9):e1116-e1117. Doi:10.1016/S2214-109X(20)30319-3
83. Wedi COO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV. 2016;3(1):e33-48. Doi:10.1016/S2352-3018(15)00207-6
84. Chetty T, Singh Y, Odendaal W, et al. Intervention in Mothers and Newborns to Reduce Maternal and Perinatal Mortality in 3 Provinces in South Africa Using a Quality Improvement Approach: Protocol for a Mixed Method Type 2 Hybrid Evaluation. JMIR Res Protoc. 2023;12:e42041. Doi:10.2196/42041
85. Flaherman VJ, Afshar Y, Boscardin WJ, et al. Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(9):e2810-e2813. Doi:10.1093/cid/ciaa1411
86. Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review. Obstet Gynecol. 2020;136(2):303-312. Doi:10.1097/AOG.0000000000004010
87. Kim DH. Clinical implications of coronavirus disease 2019 in neonates. Clin Exp Pediatr. 2021;64(4):157-164. Doi:10.3345/cep.2020.01795
88. Woodworth KR, Olsen EO, Neelam V, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635-1640. Doi:10.15585/mmwr.mm6944e2
89. Smith ER, Oakley E, Grandner GW, et al. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health. 2023;8(1):e009495. Doi:10.1136/bmjgh-2022-009495
90. Increased pregnancy problems with COVID-19 – meta-analysis and letter to editor – April 2021. VitaminDWiki. Accessed July 27, 2023. https://vitamindwiki.com/Increased+pregnancy+problems+with+COVID-19+%E2%80%93+meta-analysis+and+letter+to+editor+%E2%80%93+April+2021
91. Vivanti AJ, Vauloup-Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11(1):3572. Doi:10.1038/s41467-020-17436-6
92. Benny M, Bandstra ES, Saad AG, et al. Maternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates. Pediatrics. 2023;151(5):e2022058271. Doi:10.1542/peds.2022-058271
93. Falahi S, Abdoli A, Kenarkoohi A. Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives. New Microbes New Infect. 2023;53:101135. Doi:10.1016/j.nmni.2023.101135
94. Tuan JJ, Sharma M, Kayani J, et al. Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO). BMC Infect Dis. 2023;23(1):258. Doi:10.1186/s12879-023-08198-9
95. Lin CY, Cassidy AG, Li L, Prahl MK, Golan Y, Gaw SL. Nirmatrelvir–Ritonavir (Paxlovid) for Mild Coronavirus Disease 2019 (COVID-19) in Pregnancy and Lactation. Obstet Gynecol. 2023;141(5):957-960. Doi:10.1097/AOG.0000000000005152
96. Shimabukuro T, Covid C. COVID-19 vaccine safety update.
97. Beharier O, Plitman Mayo R, Raz T, et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest. 2021;131(13):e150319, 150319. Doi:10.1172/JCI150319
98. Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184(6):1486-1499. Doi:10.1016/j.cell.2021.02.031
99. Rahmati M, Yon DK, Lee SW, et al. Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis. Rev Med Virol. 2023;33(3):e2434. Doi:10.1002/rmv.2434
100. Collier A ris Y, McMahan K, Yu J, et al. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. JAMA. 2021;325(23):1-11. Doi:10.1001/jama.2021.7563